CohBar to Announce 2020 Third Quarter Financial Results and Provide Business Update on November 16, 2020 Nov 2, 2020
CohBar to Host Key Opinion Leader Meeting on Antifibrotic Peptides for the Potential Treatment of Idiopathic Pulmonary Fibrosis Oct 29, 2020
CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model Oct 26, 2020
CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference Oct 8, 2020
